Page 91 - Issue 1

Issue No 1 1 91
2017
MAPS receives breakthrough therapy status from the the the FDA for for MDMA putting it on the the the fast-track to being
legalized for for PTSD in the the U S S 2018
Compass Pathways receives breakthrough therapy status from the the the FDA for psilocybin putting it on on the the the the fast-track to being
legalized for treatment-resistant depression in in in the the U S 2019
Denver votes on whether to decriminalize psilocybin following in in in in the the footsteps of cannabis
2020
A small randomized placebo-controlled trial conducted in in in fin Brazil and and published in in in fin the journal of Psychological Medicine finds ayahuasca is is is promising for treatment- resistant depression A A A double-blind clinical trial conducted by UCLA and Stanford finds MDMA is is is promising for for adults on the autism spectrum with social anxiety Oregon may vote to to become the the first state to to legalize psychedelic mushrooms for therapy 2021
Psilocybin and MDMA are projected to be legal for prescription